Calum MacLean to Head Lanxess-Advent JV
German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for high-performance engineering plastics.
People
Bayer CEO Baumann Headed for early Exit?
CEO Werner Baumann may be headed for an early exit from Bayer, Bloomberg reports.
Rentschler Appoints Mark Caswell as Vice President, US Facility Site Head
Rentschler Biopharma has appointed Mark Caswell as Vice President and Site Head. He joined Rentschler in July 2022 and is managing all operations at the company’s US facilities in Milford, MA.
Yann Lissillour Appointed CEO of Safic-Alcan
Martial Lecat and Philippe Combette will cease their functions within the Safic-Alcan Executive Committee on Apr. 1, 2022. At the same time, Combette, current Chairman of Safic-Alcan, will hand over the presidency of the group to Yann Lissillour. Lectat and Combette joined Safic-Alcan in June and October 1988 respectively.
DMC Appoints Kelly Smith as Vice President R&D
US biobased chemical company DMC Biotechnologies has appointed Kelly Smith as Vice President R&D. Previously, she was head of bioprocessing and formulation development at Joyn Bio.
Akhil Ravi Named CEO of Aurigene Pharmaceutical Services
Dr. Reddy's has appointed Akhil Ravi as CEO for its wholly-owned subsidiary Aurigene Pharmaceutical Services effective Feb. 1, 2022.
Ib Jensen Appointed as CFO of Perstorp
Perstorp has appointed Ib Jensen as new CFO, effective Feb. 1, 2022. He takes over the CFO role from Ulf Berghult, who will leave Perstorp in April.
Gelest Names Jonathan Goff as President
US chemicals and materials group Gelest has named Jonathan Goff as President effective immediately. He succeeds Barry Arkles, founder of Gelest, who has officially stepped down from his role as CEO on Dec. 31, 2021.
GSK Lures Pfizer’s Vaccines R&D Chief Away
Britain’s largest drugmaker, GlaxoSmithKline (GSK) has landed a major coup, luring Pfizer’s vaccines R&D chief away, as it tries to regain its position in the top tier of the vaccine league and build up its presence in the mRNA field. On Dec. 3, Philip Dormitzer, who had served as the US pharma giant’s chief scientific officer for RNA and viral vaccines since 2015, will say goodbye to New York and, figuratively, at least, hello to London.
Philipp Morgenthaler to Join Circa as Head of Manufacturing
Philipp Morgenthaler will join sustainable biochemicals company Circa Group as Global Head of Manufacturing.
Perstorp Appoints Patrice Pinsard as EVP Strategic Markets & Innovation
Perstorp has appointed Patrice Pinsard as EVP Strategic Markets & Innovation, effective Oct. 18, 2021.
Solvay Appoints Pascal Chalvon Demersay as Chief Sustainability and Government Affairs Officer
Solvay has appointed Pascal Chalvon Demersay to chief sustainability and government affairs officer, effective July 1, 2021, integrating the new responsibilities to his current role as chief sustainability officer.
Solvay Appoints Carmelo Lo Faro as President of Materials Segment
Solvay has appointed Carmelo Lo Faro, previously president of the company’s composite materials business unit, as president of the materials segment, effective immediately.
Pilar Castellanos Pineda Appointed as Managing Director of IMCD Colombia
Speciality chemicals and ingredients distributor IMCD has appointed Pilar Castellanos Pineda as Managing Director of IMCD Colombia effective May 25, 2021.
Ann Verlinden Appointed as Managing Director of Catalisti
Belgian spearhead cluster Catalisti has appointed Ann Verlinden as its new Managing Director. She will succeed Jan Van Havenbergh as of Apr. 5, 2021.
PolyPeptide Group Appoints Raymond De Vré as new CEO
PolyPeptide Group has appointed Raymond De Vré as its new Chief Executive Officer (CEO). He will succeed Jane Salik who, after 15 years in this position, will concentrate on her role on the Board of Directors.
Adrenomed Appoints Wolfgang Baiker as CEO
German biopharmaceutical company Adrenomed has appointed Wolfgang Baiker as Chief Executive Officer (CEO), effective Jan. 1, 2021.
WeylChem Appoints Johannes Kanellakopoulos as Head of Marketing & Sales Custom Manufacturing
WeylChem has appointed Johannes Kanellakopoulos as new Head of Marketing & Sales for its growing Custom Manufacturing business. He took over the role on Sept. 1 with the aim of fully exploiting the group's capabilities.
Perstorp Appoints Ulf Berghult as New CFO
Ulf Berghult has been appointed as Perstorp’s new CFO as of mid-February. He joins the group from Trelleborg, where he held the position as CFO since 2012.
Bernhard Müller New Managing Director of Minascent Technologies
With effect from May 1, 2020 the executive committee of the Louvain-la-Neuve, Belgium-based Minafin Group has appointed Bernhard Müller as Managing Director of its affiliate Minascent Technologies.
CEFIC Appoints Frans Stokman as Executive Director of Petrochemicals Europe
The European Chemical Industry Council (CEFIC) has appointed Frans Stokman as new Executive Director of its industry sector Petrochemicals Europe, effective immediately.
Michael Zobel to Head Lanxess Subsidiary Saltigo
Michael Zobel (50), currently head of the High Performance Materials (HPM) business unit, will take over the management of Lanxess subsidiary Saltigo from Torsten Derr (50) on June 1, 2020.
